Nasdaq GlobeNewswire

Novavax Receives the Tech Council of Maryland’s Chairman’s Award

Del

GAITHERSBURG, Md., 2016-05-12 14:30 CEST (GLOBE NEWSWIRE) --

Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it received the Tech Council of Maryland’s (TCM) Chairman’s Award. The award was announced at the TCM Industry Award Celebration on May 11, 2016. 

The Chairman's Award is presented to a member company or individual that best exemplifies excellence in Maryland's technology or life science industry.  The Award recognizes a company that is a pillar in the community, not only through market success or job creation, but by consistently giving back, getting involved and advancing the climate for innovation.

“Novavax is the embodiment of what we look for when selecting an honoree for the Chairman’s award. The company has built a successful business, employing 450 people in Maryland who are developing vaccines that positively impact global health, and has played an important role in fostering growth of the state’s life sciences community,” said Rene B. LaVigne, TCM chairman-elect and president and CEO of Iron Bow Technologies. "TCM appreciates Novavax’s significant contributions to the association, the state’s economy and innovations in healthcare."

“I am honored to accept this award on behalf of the entire Novavax team,” said Stanley C. Erck, President and CEO, Novavax. “The Tech Council of Maryland facilitates a collaborative community of technology and life science companies who aim to make an impact in our region and beyond. We are thrilled that this award recognizes the hard work and dedication of our more than 450 SuperNovas, our groundbreaking achievements in developing novel vaccines and our commitment to the Maryland life science and technology community.”

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

         Contact:
         
         Novavax, Inc.
         Barclay A. Phillips
         SVP, Chief Financial Officer and Treasurer
         
         Andrea N. Flynn, Ph.D.
         Associate Director, Investor Relations
         
         ir@novavax.com
         240-268-2000
         
         Russo Partners, LLC
         David Schull
         Todd Davenport, Ph.D.
         
         david.schull@russopartnersllc.com
         todd.davenport@russopartnersllc.com
         212-845-4271

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Dog Meat Free Indonesia : Sickening animal cruelty at Indonesia's "extreme" markets where dogs and cats are bludgeoned, blowtorched alive24.1.2018 09:30Pressemelding

Government urged to take immediate action to protect animals and public health LONDON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- The Indonesian government is being urged to shut down the country's cruel live animal markets, where thousands of dogs and cats a week are bludgeoned in public, blowtorched whilst still alive, and butchered for eating. Campaigners from the Dog Meat-Free Indonesia coalition filmed at two of the most notorious of Indonesia's 200 live animal markets in North Sulawesi, "Tomohon Extreme Market" and Langowan Market, to expose the horrifying suffering routinely endured by animals. Live dogs and cats are seen trembling in cages as one by one they are beaten over the head, howling in pain. Lola Webber, Dog Meat-Free Indonesia campaign coordinator, said: " It was like walking through hell. The dogs huddled together in cages , trembling with fear as they watched others being killed around them , waiting their turn. The sight of absolute terror in their eyes, the thumping of the

Promethean Expands Educational Display Portfolio to Create Immersive Classroom Experiences24.1.2018 09:18Pressemelding

Seattle, Wash., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Promethean TM, a global education technology company, announced expansions to its interactive flat panel portfolio which includes the market-leading ActivPanel and ActivPanel i-Series. The ActivPanel continues to offer the industry's most natural writing experience using InGlassTM technology, enabling both teachers and students to collaborate in front of the class with ease. The ActivPanel i-Series is an essential interactive flat panel for customers looking to replace their projector-based systems with a long-term, reliable solution. "Educators want technology that works as they do - flexible and able to adapt to their teaching styles in any classroom setting," said Ravi Angadi, Chief Products and Strategy Officer, Promethean. "At Promethean, we strive to create a dynamic ecosystem to enhance teacher productivity, providing educators with the latest innovative education technologies that are intuitive and immersive. With access to an e

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer23.1.2018 21:11Pressemelding

DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies-the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP)-have updated their 2013 evidence-based guideline. Published today in early online release, the "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors," continues to set standards for the molecular analysis of lung cancers for test results that effectively guide targeted therapy and treatment. Targeted cancer therapies are drugs or other treatments that block the spread of cancer by interfering with specific molec

CashBet Seeks $40 Million for World's Only Complete Crypto-Ready Mobile iGaming Platform23.1.2018 16:31Pressemelding

Gaming and cryptocurrency industry leaders develop blockchain-based iGaming platform improving trust, speed, access, costs, and content availability OAKLAND, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Leading mobile-first iGaming platform provider CashBet (https://coin.cashbet.com/) today announced it seeks to raise $40 million through an Initial Coin Offering (ICO) to develop the world's first complete crypto-ready mobile iGaming platform. Interactive gaming, which includes real money, social, skill-based, esports and sports betting, hit $91 billion in 2016, led by mobile gaming. Despite strong growth, current iGaming operations continue to face three major issues: trust, speed, and cost. CashBet is the first and only vertically integrated iGaming solution to leverage blockchain technology for transparent operations, increased speed, and lower transaction fees. The CashBet Coin will be available in pre-sale starting January 24, 2018 at 5:00 p.m. GMT, with a 20 percent discount offered.

BrandSafway Announces Acquisition of Venko Groep BV23.1.2018 16:30Pressemelding

Combined customers to benefit from broader range of services and greater depth of expertise KENNESAW, GA, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has acquired Venko Groep BV, a portfolio company of Mentha Capital, effective January 1, 2018. Moving forward, the company will operate as Venko, A BrandSafway Company and become a part of Brand Energy & Infrastructure Services (Brand) in Europe. "We're excited to announce the closing of the acquisition of Venko," said Dave Witsken, President of Energy and Industrial for BrandSafway. "Venko is a leading offshore coatings maintenance provider for platforms in Europe. By leveraging the highly specialized knowledge and capabilities of Venko, we will be able to provide expanded coatings services to Brand's European customers. At the same time, with our support, Venko will now be able to offer their customers a broader inventory of access equipment and additional industrial services, such as insulation an

Mitratech's TeamConnect Rated Most Widely Used Matter Management System in HBR Consulting's Annual Law Department Survey23.1.2018 15:00Pressemelding

HBR's Annual Survey further validates TeamConnect's market leadership AUSTIN, Texas, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Mitratech, the leading provider of legal, compliance, and risk management software solutions announced that TeamConnect, the market-leading ELM (enterprise legal management) platform, was rated the most widely used matter management system and the second most widely used e-Billing system in the 2017 HBR Consulting (HBR) Law Department Survey. HBR's Law Department Survey released this month rated Mitratech's TeamConnect as the most widely used system for matter management out of the 13 systems included in the survey. All told, Mitratech's ELM solutions accounted for more than a third of the matter management user base. TeamConnect also was rated for the third year in a row as the second most widely used e-Billing system, continuing a years-long trend of customers shifting to Mitratech's integrated ELM platform from other point solutions. Customer satisfaction continues

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom